Skip to content

Molecular Partners AG

MOLN· NasdaqCore metricsCIK 1745114

Biological products, except diagnostic substances175 peers

Last sale
Nov 5, 2026 · +0.58%
Market cap
$139.70M
40.37M shares
Filings
121
CHF 0.00
FY 2025−100.0% FY25 yoy
-CHF 61.65M
FY 2025N/M FY25 yoy
-CHF 58.12M
FY 2025N/M FY25 yoy
-CHF 51.97M
FY 2025derivedN/M FY25 yoy
-CHF 1.65
FY 2025N/M FY25 yoy
CHF 82.65M
FY 2025+29.4% FY25 yoy
$139.70M
—
—
—
—
—

Price

$3.4615.20%$0.62past year
Nov 5, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

CHF 0.00FY 2025
CHF 189.60M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31CHF 0reported
FY 20242024-12-31CHF 4,970,000reported
FY 20232023-12-31CHF 7,038,000reported
FY 20222022-12-31CHF 189,600,000reported
FY 20212021-12-31CHF 9,754,000reported
FY 20202020-12-31CHF 9,344,000reported
FY 20192019-12-31CHF 20,383,000reported

Capital returns

Dividends and buybacks · FY2020 to FY2024
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2024—CHF 0.00CHF 0.00—40.36M sh+11.0%—
FY2023—CHF 0.00CHF 0.00—36.35M sh+0.9%—
FY2022—CHF 631.00KCHF 631.00K—36.04M sh+11.6%0.5%
FY2021—CHF 0.00CHF 0.00—32.29M sh——
FY2020—CHF 0.00CHF 0.00————

Biological products, except diagnostic substances

Molecular Partners AG is the 105th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Molecular Partners AG · CIK 1745114 · Engraved from SEC EDGAR